Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Respiratory Insufficiency

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Respiratory Insufficiency in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, S; Shi, F; Zhang, S; Zhang, W1
Nagase, T1
Taggart, DP1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Respiratory Insufficiency

ArticleYear
[Respiratory failure].
    Nihon rinsho. Japanese journal of clinical medicine, 2013, Volume: 71, Issue:6

    Topics: Acute Lung Injury; Animals; Cytokines; Humans; Platelet Activating Factor; Respiratory Distress Syndrome; Respiratory Insufficiency

2013

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Respiratory Insufficiency

ArticleYear
Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation.
    The Annals of thoracic surgery, 2001, Volume: 71, Issue:1

    Topics: Adult; Aged; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Imidazoles; Leucine; Lung; Male; Middle Aged; Platelet Activating Factor; Respiratory Insufficiency

2001

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Respiratory Insufficiency

ArticleYear
The expression of Nrf2-ARE signaling pathway combined with plasma platelet activating factor in elderly patients with respiratory failure and its correlation with lung function.
    Panminerva medica, 2023, Volume: 65, Issue:2

    Topics: Aged; Humans; Lung; NF-E2-Related Factor 2; Platelet Activating Factor; Respiratory Insufficiency; Signal Transduction

2023